January 24, 2018 / 2:18 PM / in 4 minutes BRIEF-CAS Group Delivers Letter To The Stockholders Of Aviragen Reuters Staff 
Jan 24 (Reuters) - Aviragen Therapeutics Inc: 
* CAS GROUP DELIVERS LETTER TO THE STOCKHOLDERS OF AVIRAGEN 
* CAS GROUP SAYS PROPOSED MERGER BETWEEN AVIRAGEN AND VAXART NOT IN BEST INTERESTS OF STOCKHOLDERS OF AVIRAGEN 
* CAS GROUP - “BELIEVE VAXART‘S TRUE VALUE IS LOWER THAN THAT INDICATED IN PROPOSED MERGER” 
* CAS GROUP SAYS “‍BELIEVE VAXART‘S TRUE VALUE IS LOWER THAN THAT INDICATED IN PROPOSED MERGER AND THAT VAXART IS NOT READY TO BE A PUBLIC COMPANY”​ 
* CAS GROUP - DIGIRAD CORP, EAST HILL MANAGEMENT, THOMAS CLAY (COLLECTIVELY CAS GROUP) OWN ABOUT 8.3 PERCENT OF OUTSTANDING AVIRAGEN SHARES 
* CAS GROUP - HAS NOMINATED A SLATE OF DIRECTORS FOR AVIRAGEN‘S BOARD Source text for Eikon: Further company coverage: